eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Thornton & Ross Ltd

Telephone: +44 (0)1484 842217
Fax: +44 (0)1484 847301
WWW: http://www.thorntonandross.com
Medical Information Direct Line: +44(0)1484 848 251
Medical Information e-mail: phv@thorntonross.co.uk
Customer Care direct line: +44(0)1484 842 217
Medical Information Fax: +44(0)1484 847 301

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 21/11/2011
SPC Mentholated Bronchial Balsam


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Mentholated Bronchial Balsam or Covonia Mentholated Cough Mixture or Superdrug Mentholated Bronchial Mixture or Gordons Chesty Cough Linctus.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Menthol BP

4.0mg/5ml

Squill Tincture HSE

0.6ml/5ml

Liquorice Liquid Extract BP

0.125ml/5ml


Go to top of the page
3. PHARMACEUTICAL FORM

Mixture


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the symptomatic relief of productive (chesty) coughs and sore throats.


Go to top of the page
4.2 Posology and method of administration

Oral

Recommended doses

Adults, the elderly and children over 12 years: one or two 5ml spoonfuls.

Children 5 – 12 years: one 5ml spoonful.

Dosage schedule

The dose to be taken every four hours if required.


Go to top of the page
4.3 Contraindications

Contraindicated in patients with known hypersensitivity to any of the ingredients. Also contraindicated in patients with cardiac disorders.


Go to top of the page
4.4 Special warnings and precautions for use

If symptoms persist or worsen consult your doctor.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Toxicity of squill glycosides may be increased when given in combination with thiazides or loop diuretics, as these may cause hypokalaemia and hypomagnesaemia which may lead to cardiac arrhythmias.

When used with carbenoxolone it may produce sodium and water retention and hypokalaemia, and may give rise to greater toxicity of squill.


Go to top of the page
4.6 Pregnancy and lactation

There are no adverse reports when used in recommended doses. However, as with all medicines care should be taken when using this product in pregnancy and medical advice sought if necessary.


Go to top of the page
4.7 Effects on ability to drive and use machines

None


Go to top of the page
4.8 Undesirable effects

No adverse effects have been reported with this product, however, a few cases of hypersensitivity reactions to menthol have been reported. These include generalised urticaria and flushing, menthol may give rise to contact dermatitis.

Liquorice may cause sodium and water retention, and hypokalaemia.


Go to top of the page
4.9 Overdose

Ingestion of large doses of the active ingredients has been reported to cause the following effects: gastrointestinal disturbances such as abdominal pain, nausea, vomiting and diarrhoea would be expected to occur with the menthol and squill. Common symptoms of digoxin overdosage include headache, facial pain, fatigue, weakness, dizziness, drowsiness, disorientation, mental confusion, bad dreams and more rarely delirium, acute psychoses, and hallucinations. Convulsions have been reported. Visual disturbances including blurred vision may occur. Colour vision may be affected with objects appearing yellow or less frequently green, red, brown, blue or white.

Adverse effects on the heart may result from the cardiac glycosides in squill. Toxic doses may cause or aggravate heart failure. Supraventricular or ventricular arrhythmias and defects of conduction are common and may be an early indication of excessive dosage.

In addition CNS effects such as vertigo, ataxia and drowsiness have been reported after ingestion of large quantities of menthol; reported adverse effects following excessive ingestion of liquorice include hypertension, congestive heart failure, cardiac arrest, headache, muscle weakness, myopathy, myoglobinuria, paralysis, hyperprolactinaemia and amenorrhoea. In the unlikely event of overdosage with this preparation, gastric lavage and / or symptomatic treatment together with supportive measures should be employed.

Treatment of acute digoxin poisoning consists of emptying the stomach by emesis or lavage. Activated charcoal may be given. Cardiac toxicity should be treated under ECG control and serum electrolytes should be monitored. Anti-arrhythmic treatment may be necessary and should be determined by the specific arrhythmia present. Atropine may be given intravenously to control bradycardia and in patients with heart block; cardiac pacing may be necessary if atropine is not effective. Cholestyramine or colestipol may be of use in increasing the elimination of cardiac glycosides.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Menthol dilates the blood vessels causing a sensation of coldness followed by analgesic effect. It is used to relieve the symptoms of bronchitis, sinusitis and similar conditions.

Squill has an irritant effect on the gastric mucosa, it has a reflex expectorant action.

Liquorice is a demulcent and mild expectorant.


Go to top of the page
5.2 Pharmacokinetic properties

After absorption menthol is excreted in the bile and urine as a glucuronide.

Squill glycosides are poorly absorbed from the gastro-intestinal tract, they are of short acting duration and are not cumulative; they are excreted in the urine and faeces.

No information is available on the pharmacokinetics of liquorice.


Go to top of the page
5.3 Preclinical safety data

None


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Peppermint oil BP, anise oil BP, capsicum tincture BPC, syrup BP, liquid glucose BPC 1963, veegum k, sodium nipasept, glycerol BP, caramel BPC and purified water BP.


Go to top of the page
6.2 Incompatibilities

None known


Go to top of the page
6.3 Shelf life

150ml: 36 months unopened

200ml: 36 months unopened


Go to top of the page
6.4 Special precautions for storage

Store below 25°C


Go to top of the page
6.5 Nature and contents of container

150ml: amber glass bottle with plastic cap with EPE/Saranex liner or white plastic child resistant cap with EPE/Saranex liner or white 28mm cap with tamper evident band and EPE Saranex liner or white 28mm Child-resistant cap with Tamper Evident band and EPE/Saranex Liner

200ml: amber glass bottle with plastic cap with EPE/Saranex liner or white plastic child resistant cap with EPE/Saranex liner or white 28mm cap with tamper evident band and EPE Saranex liner or white 28mm Child-resistant cap with Tamper Evident band and EPE/Saranex Liner


Go to top of the page
6.6 Special precautions for disposal and other handling

None


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

L.C.M. Ltd.,

Linthwaite Laboratories

Huddersfield

HD7 5QH


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 12965/0026


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

24.03.94 / 13.04.99


Go to top of the page
10. DATE OF REVISION OF THE TEXT

August 2004


Go to top of the page
11 DOSIMETRY

Not Applicable


Go to top of the page
12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

Not Applicable



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/25344/SPC/


Active Ingredients/Generics

 
   menthol
   liquorice liquid extract
   squill tincture